SYNTHESIS AND FORMULATION OF IBUPROFEN PRO-DRUGS FOR ENHANCED TRANSDERMAL ABSORPTION
Objectives: The aim is to synthesize ibuprofen prodrugs that have more suitable physicochemical properties and formulate them into a liquid formulation for topical administration. The transdermal delivery (TDD) is one of the most attractive routes for drug administration as it eliminates the GIT absorption variable, improves patient compliance and also reduces drug plasma fluctuations. However, TDD only drugs with suitable physico-chemical properties can be absorbed. The oral administration of NSAIDs for a long time can cause gastric mucosal damage, which may result in ulceration and bleeding. Thus, the development of a TDD of NSAIDs is of great interest as it decreases GIT side effects
Methods: The synthesis of ibuprofen alkyl esters was carried out by esterification reactions with methanol, ethanol, propanol, butanol, pentanol and hexanol. The formulated samples were then subjected to stability studies according to ICH guidelines.
Results: We have successfully synthesized and characterized various esters of ibuprofen. Moreover, ibuprofen butyl ester has been prepared as topical solutions. The formulated TDD was tested for stability according to ICH guidelines and the results showed no changes in the initial appearance during three months of study at room temperature & at 40 Â°C.
Conclusion: The assay and pH were within the pharmacopeial limits during the period of the study. In conclusion, stable topical formulation of Ibuprofen esters was obtained.
2. Aulton ME, Taylor KM. Aulton's pharmaceutics: the design and manufacture of medicines: Elsevier Health Sciences; 2013.
3. DJG. Dermatology An Illustrated Colour Text; 2002.
4. Flynn GL. Cutaneous and transdermal delivery: processes and systems of delivery. Drugs Pharm Sci 1996;72:239-98.
5. Mccarley KD, Bunge AL. Pharmacokinetic models of dermal absorption. J Pharm Sci 2001;90(11):1699-719.
6. Manallack DT. The pKa distribution of drugs: application to drug discovery. Perspect Med Chem 2007;1:25-38.
7. Cioli V, Putzolu S, Rossi V, Scorza Barcellona P, Corradino C. The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats. Toxicol Appl Pharmacol 1979;50(2):283-9.
8. Potts RO, Guy RH. Predicting skin permeability. Pharm Res 1992;9(5):663-9.
9. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000;9(3):165-9.
10. Yano T, Nakagawa A, Tsuji M, Noda K. Skin permeability of various non-steroidal anti-inflammatory drugs in man. Life Sci 1986;39(12):1043-50.
11. Swart H, Breytenbach JC, Hadgraft J, Plessis Jd. Synthesis and transdermal penetration of NSAID glycoside esters. Int J Pharm 2005;301(1):71-9.
12. Sevelius H, Runkel R, Segre E, Bloomfield S. Bioavailability of naproxen sodium and its relationship to clinical analgesic effects. Br J Clin Pharmacol 1980;10(3):259-63.
13. Capone ML, Tacconelli S, Sciulli MG, Anzellotti P, Di Francesco L, Merciaro G, et al. Human pharmacology of naproxen sodium. J Pharmacol Exp Ther 2007;322(2):453-60.
14. Moyer S. Pharmacokinetics of naproxen sodium. Cephalalgia: an international journal of headache 1986;6:77-80.
15. Ghose AK, Crippen GM. Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions. J Chem Inf Comput Sci 1987;27:21â€“35.